Calithera Biosciences Inc expected to post a loss of 24  cents a share - Earnings Preview

Calithera Biosciences

12/03/2022 24:05

* Calithera Biosciences Inc  CALA.OQ   CALA.O  is expected
to show
no change in quarterly revenue when it reports  results on March
14 (estimated). 
    * ​Refinitiv's mean analyst estimate for Calithera
Biosciences Inc
is for a loss of 24 cents per share. For the same quarter last
year, the company reported a loss of 32 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Calithera
Biosciences Inc is $3​, above​ its last closing price of $0.47.
​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.22       -0.23      -0.15     Beat    34.2
 Jun. 30 2021  -0.24       -0.24      -0.19     Beat    20.9
 Mar. 31 2021  -0.27       -0.28      -0.28     Met     -1.4​
 Dec. 31 2020  -0.33       -0.32      -0.32     Met     1.2
 ​​Sep.        -0.31       -0.31      -0.32     Missed  -3.1
 30 2020                                                
 Jun. 30 2020  -0.33       -0.33      -0.29     Beat    13.3​
 Mar. 31 2020  -0.36       -0.36      -0.38     Missed  -5.8
 Dec. 31 2019  -0.39       -0.37      -0.39     Missed  -4.7
 This summary was machine generated March 12 at 00:05 GMT.  All
figures in US dollars  unless otherwise stated